Catherine Gardner
Obstetrics & Gynecology · Oklahoma City, OKNPI 1730270463
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,873 of the $12,066 with a category attached, or 65.2%. Organon accounts for 70.3% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $8,428, 7.8 times the $1,086 reported in 2021. Among obstetrics & gynecology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $95.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$8K
- AstraZeneca$615
- Amgen$455
- Daiichi Sankyo Inc.$361
- Abbott$322
- Agile Therapeutics, Inc.$256
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$7,87365%
- Food & beverage$4,19335%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 56 | $8,485 |
| AstraZeneca(2 entities) | 7 | $615 |
| Amgen | 5 | $455 |
| Daiichi Sankyo Inc. | 3 | $361 |
| Abbott | 3 | $322 |
| Agile Therapeutics, Inc. | 9 | $256 |
| Otsuka America Pharmaceutical, Inc. | 3 | $173 |
| AbbVie | 3 | $150 |
| Actelion Pharmaceuticals US, Inc. | 1 | $137 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Eisai Inc. | 1 | $123 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Novo Nordisk | 1 | $116 |
| Althera Pharmaceuticals LLC | 1 | $105 |
| Exact Sciences | 5 | $77 |
| Avion Pharmaceuticals | 4 | $76 |
| Merck | 4 | $63 |
| Sage Therapeutics, LLC | 3 | $52 |
| Amarin Pharma, Inc. | 2 | $43 |
| Pfizer | 2 | $40 |
| Mayne Pharma Commercial LLC | 2 | $36 |
| Therapeuticsmd, Inc. | 2 | $33 |
| Millicent US Inc | 2 | $26 |
| Bayer | 1 | $18 |
| Minerva Surgical, Inc | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,066 in reported general payments places this provider in the 95th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DottiEstradiol | 20 | $1,641 |
| Estradiol | 15 | $1,500 |
| ProgesteroneProgesterone, Micronized | 30 | $1,371 |
| Estradiol (Twice Weekly)Estradiol | 12 | $882 |
| Levothyroxine Sodium | 33 | $304 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Oklahoma City
- Tori OdanielOklahoma City$917K
- Kathleen MooreOklahoma City$795K
- Beverly VavrickaOklahoma City$22K
- Monica ReidOklahoma City$20K
- Hoda MaaroufOklahoma City$15K
- Misty WaymanOklahoma City$13K
- Catherine HildebrandOklahoma City$12K
- Kamal ShanbourOklahoma City$10K
- Darren GoffOklahoma City$10K
- Lisa CheekOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.